The global calprotectin testing market is capturing a valuation of USD 201.1 billion in 2023 and is predicted to reach an impressive USD 360.2 billion by 2033, registering a compound annual growth rate (CAGR) of 6% during the forecast period. This significant growth highlights the increasing importance and adoption of calprotectin testing in the healthcare sector.
Calprotectin testing has become an essential diagnostic tool, particularly noted for its effectiveness in detecting gastrointestinal disorders. The escalating prevalence of these disorders, coupled with an increased emphasis on early detection and diagnosis, has propelled the global demand for calprotectin testing. This demand is not only driven by patients seeking timely and accurate diagnoses but also by healthcare providers who are prioritizing preventive healthcare measures.
Get The Sample Copy Of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14504
The future of diagnostic healthcare is being shaped by the growing recognition of the value of early detection and diagnosis. Calprotectin testing is at the forefront of this transformation, providing a reliable and effective means to identify gastrointestinal disorders at an early stage. As awareness and adoption of this vital diagnostic tool continue to rise, the calprotectin testing market is poised for remarkable growth in the coming decade.
Recent Trends in the Global Calprotectin Testing Market:
The several notable trends in the global market are as follows:
- There is rising demand for non-invasive diagnostic devices by healthcare providers and patients to produce quick and accurate results.
- The prevalence of inflammatory bowel disease is growing rapidly. Therefore, the demand for calprotectin testing is increasing to monitor patients’ chronic health.
- The innovation of advanced technology devices is more reliable and tract patients’ health accurately.
- Adopting automation in calprotectin testing reduces error risk, detects efficiently, and increases productivity.
Ask for Customize Research Report: https://www.futuremarketinsights.com/customization-available/rep-gb-14504
Key Takeaways:
- The calprotectin testing market is securing a valuation of USD 360.2 billion with a CAGR of 6% by 2033.
- The United States is anticipated to lead the global market by registering a share of 25.7% by 2033.
- Japan is anticipated to register a share of 3.1% in the global market during the forecast period.
- In the historic period, the market captured a CAGR of 5.3% between 2018 and 2022.
Key Players are Executing Plans to Rise the Market Size:
The key players are executing various plans to upsurge the global market are:
- New Product Launches: key players are developing user-friendly, sustainable, and accurate testing devices in the market. They are launching these testing tools to satisfy patients’ requirements.
- Collaboration: Key companies collaborate with stakeholders, research organizations, and hospitals to enhance product quality. These collaborations help them to reach relevant customers and increase sales.
- Promotions and Marketing: Key players invest in promotional and marketing to expand their business and brand value. They promote their products on social media and educate patients about the benefits of their products.
These are a few strategies key players adopt to increase the market size:
- Actim Oy
- Calpro AS
- BÜHLMANN Laboratories AG
- EagleBio
- CerTest Biotec S.L.
- EUROIMMUN Medizinische Labordiagnostika AG
- Boditech Med Inc.
- Biohit Oyj
- American Laboratory Products Company, Ltd.
- DIAsource ImmunoAssays S.A
- R-Biopharm AG.
Recent Developments in the Global Market are:
- In 2020, Biohit Oyj launched its new product Calprotectin ELISA kit. It is designed to collect human samples to monitor inflammatory bowel disease.
- In 2021, Techlab Inc launched Enteric BioFire FilmArray Panel to detect gastrointestinal infections.
- In 2021, EKF Diagnostics launched its point-of-care device to measure calprotectin. This device provides accurate and fast results to monitor patients’ diseases.
Get a Checkout on the Report: https://www.futuremarketinsights.com/checkout/14504
Calprotectin Testing Market by Category:
By Test Kits:
- Calprotectin ELISA Test Kits
- Calprotectin Rapid Testing Kits
By Sample:
- Stool, Blood Serum/Plasma
- Other Biological Samples
By Indication:
- Irritable Bowel Syndrome
- Ulcerative Colitis
- Crohn’s Disease
- Colorectal Cancer
By End User:
- Hospitals
- Diagnostic Laboratories
- Specialty Clinics
Region:
- North America
- Europe
- Latin America
- Asia Pacific
- The Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
